Photo from wikipedia
∼3–10% of asthma patients suffer from severe asthma, representing a substantial burden for affected patients due to distinct symptoms, frequent exacerbations and numerous medication side-effects [1]. Despite the rather small… Click to show full abstract
∼3–10% of asthma patients suffer from severe asthma, representing a substantial burden for affected patients due to distinct symptoms, frequent exacerbations and numerous medication side-effects [1]. Despite the rather small percentage, patients with severe asthma are responsible for up to 50% of direct and indirect costs associated with bronchial asthma [2]. Hospitalisations and medications are the main driver for high economic costs, but indirect costs including lost work days or loss in productivity due to sickness also lead to steadily increasing healthcare expenses [3].
Journal Title: ERJ Open Research
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!